HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound

Executive Summary

Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.

You may also be interested in...

Recordati Posts 2021 Sales Rise As Market Recovers

Italy's Recordati attributed a solid rise in OTC sales in 2021 to the recovery of the European market as the COVID-19 pandemic loosened its grip.

Sun Pharma Grows OTC Offering In Romania With Uractiv Brand Acquisition

India's Sun Pharma has expanded the portfolio of its Romanian subsidiary Terapia with the acquisition of the Uractiv urinary tract health brand.

Futura Pens Deal With Cooper To Launch Erectile Dysfunction Gel In Europe

Futura Medical's novel OTC topical erectile dysfunction treatment MED3000 will be launched across numerous European markets by France's Cooper Consumer Health.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts